GeneDx Holdings Corp. (WGS) Debt Components
- 2026-06-30: Long-term Debt, Current MaturitiesUSD $0.00; Long-term Debt, Excluding Current MaturitiesUSD $96.84M; Long-term DebtUSD $100.00M; Long-Term Debt, Maturity, Year OneUSD (m).
- 2026-03-31: Long-term Debt, Current MaturitiesUSD $0.00; Long-term Debt, Excluding Current MaturitiesUSD $96.73M; Long-term DebtUSD $100.00M; Long-Term Debt, Maturity, Year OneUSD (m).
- 2025-12-31: Long-term Debt, Current MaturitiesUSD $4.54M; Long-term Debt, Excluding Current MaturitiesUSD $48.18M; Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
- 2025-12-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD $54.54M; Long-Term Debt, Maturity, Year OneUSD $4.54M.
GeneDx Holdings Corp. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Year Five USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Long-term Line of Credit USD | Long-Term Debt, Maturity, after Year Five USD | Debt Instrument, Interest Rate, Stated Percentage pure |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $96.84M | $100.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $0.00 | $96.73M | $100.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $4.54M | $48.18M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | (m) | $54.54M | $4.54M | $0.00 | $50.00M | $0.00 | $0.00 | (m) | (m) | (m) | (m) |
| 2025-09-30 | $1.23M | $51.58M | $54.85M | $1.24M | $1.26M | $51.28M | $762.00K | (m) | $305.00K | (m) | (m) | (m) |
| 2025-06-30 | $1.22M | $51.68M | $55.15M | $1.24M | $1.26M | $51.28M | $762.00K | (m) | $608.00K | (m) | (m) | (m) |
| 2025-03-31 | $1.22M | $51.79M | $55.45M | $1.24M | $1.26M | $51.28M | $762.00K | (m) | $910.00K | (m) | (m) | (m) |
| 2024-12-31 | $1.21M | $51.91M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | $55.75M | $1.21M | $1.24M | $1.26M | $51.28M | $762.00K | (m) | (m) | (m) | (m) |
| 2024-09-30 | $1.21M | $52.03M | $56.05M | $1.21M | $1.24M | $1.26M | $51.28M | (m) | $299.00K | (m) | (m) | (m) |
| 2024-06-30 | $1.10M | $52.16M | $56.25M | $1.21M | $1.24M | $1.26M | $51.28M | (m) | $497.00K | (m) | (m) | (m) |
| 2024-03-31 | $798.00K | $52.29M | $56.25M | $1.21M | $1.24M | $1.26M | $51.28M | (m) | $497.00K | (m) | (m) | (m) |
| 2023-12-31 | (m) | $52.69M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $497.00K | (m) | $56.25M | $497.00K | $1.21M | $1.24M | $1.26M | $51.28M | (m) | (m) | $762.00K | (m) |
| 2023-09-30 | $198.00K | $6.05M | $6.25M | $497.00K | $1.21M | $1.23M | $1.26M | (m) | $0.00 | (m) | (m) | (m) |
| 2023-06-30 | $0.00 | $6.25M | $6.25M | $497.00K | $1.21M | $1.23M | $1.26M | (m) | $0.00 | (m) | (m) | (m) |
| 2023-03-31 | $0.00 | $6.25M | $6.25M | $497.00K | $1.21M | $1.23M | $1.26M | (m) | $0.00 | (m) | (m) | (m) |
| 2022-12-31 | $4.75M | $6.25M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | $11.00M | $4.75M | $497.00K | $1.21M | $1.23M | $1.26M | (m) | (m) | $2.05M | 4.00% |
| 2022-09-30 | $349.00K | $10.65M | $11.00M | $875.00K | $2.13M | $2.17M | $2.22M | (m) | $0.00 | (m) | (m) | (m) |
| 2022-06-30 | $0.00 | $11.00M | $11.00M | $875.00K | $2.13M | $2.17M | $2.22M | (m) | $0.00 | $0.00 | (m) | (m) |
| 2022-03-31 | $0.00 | $11.00M | $11.00M | $875.00K | $2.13M | $2.17M | $2.22M | (m) | $0.00 | $0.00 | (m) | (m) |
| 2021-12-31 | $0.00 | $11.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | $11.00M | $0.00 | $875.00K | $2.13M | $2.17M | $2.22M | (m) | $0.00 | $3.60M | 4.00% |
| 2021-11-15 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 4.00% |
| 2021-09-30 | (m) | $11.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | $0.00 | (m) | $11.00M | $0.00 | $875.00K | $2.13M | $2.17M | (m) | $0.00 | (m) | (m) | (m) |
| 2021-06-30 | (m) | $18.03M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $18.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $1.77M | $18.97M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |